Figure 1. Effect of guide sequence extension on Cas9 activity.
(A) Schematic showing Cas9 with matching or mismatching sgRNA sequences targeting the human EMX1 locus. (B) SURVEYOR assay gel showing comparable modification of target 1 by sgRNAs bearing 20- and 30-nt long guide sequences. (C) Northern blot showing that extended sgRNAs are largely reverted to 20-nt guide-length sgRNAs in HEK 293FT cells.